Results 21 to 30 of about 28,220 (90)

Diagnostic role of radionuclide methods in patients with pyelonephritis

Počki, 2018
Acute and chronic forms of pyelonephritis are the most common diseases of the urinary system in all age groups. The incidence rate of acute pyelonephritis in children is 19.1 per 1000, chronic pyelonephritis — 5–12.5 per 1000 people. In this paper, based
P.O. Korol
doaj   +1 more source

Personalized molecular visualization and radiotheranostics of adrenal tumors

Медицинский вестник Юга России, 2022
Th e diagnosis of adrenal tumors has improved signifi cantly over the past decades thanks to laboratory research and anatomical imaging techniques. In some cases, these methods make it possible to distinguish a benign tumor from a malignant one, and in ...
D. D. Omelchuk, M. V. Degtyarev, P. O. Rumyantsev   +2 more
doaj   +1 more source

Imaging Transgene Expression with Radionuclide Imaging Technologies

Neoplasia: An International Journal for Oncology Research, 2000
A variety of imaging technologies are being investigated as tools for studying gene expression in living subjects. Noninvasive, repetitive and quantitative imaging of gene expression will help both to facilitate human gene therapy trials and to allow for
S.S. Gambhir, H.R. Herschman, S.R. Cherry, J.R. Barrio, N. Satyamurthy, T. Toyokuni, M.E Phelps, S.M. Larson, J. Balatoni, R. Finn, M. Sadelain, J. Tjuvajev, R. Blasbergt   +12 more
doaj   +1 more source

Biomarkers in Prostate-Specific Membrane Antigen Theranostics

Diagnostics, 2021
Theranostics of prostate cancer (PC) represents a growing area of development of imaging agents and targeted radionuclide therapeutics against a major target, prostate specific membrane antigen (PSMA).
Panagiotis J. Vlachostergios, Ioannis Zachos, Vassilios Tzortzis   +2 more
doaj   +1 more source

Advances in targeted Alpha therapy for prostate cancer [PDF]

, 2019
BACKGROUND: Amongst therapeutic radiopharmaceuticals, targeted alpha therapy (TαT) can deliver potent and local radiation selectively to cancer cells as well as the tumor microenvironment and thereby control cancer while minimizing toxicity.
De Vincentis, G, Gerritsen, W, Gschwend, JE, Hacker, M, Lewington, V, O'Sullivan, JM, Oya, M, Pacilio, M, Parker, C, Sartor, O, Shore, N, Targeted Alpha Therapy Prostate Working Group   +11 more
core   +2 more sources

Radionuclide Small Intestine Imaging

Gastroenterology Research and Practice, 2013
The aim of this overview article is to present the current possibilities of radionuclide scintigraphic small intestine imaging. Nuclear medicine has a few methods—scintigraphy with red blood cells labelled by means of Tc99m for detection of the source of
Jiri Dolezal, Marcela Kopacova
doaj   +1 more source

An experimental study on the application of radionuclide imaging in repair of the bone defect

Biomolecules & Biomedicine, 2011
The aim of our study was to validate the effect of radionuclide imaging in early monitoring of the bone’s reconstruction, the animal model of bone defect was made on the rabbits repaired with HA artificial bone.
Weimin Zhu, Daping Wang, Xiaojun Zhang, Wei Lu, Jianquan Liu, Liangquan Peng, Hao Li, Yun Han, Yanjun Zeng   +8 more
doaj   +1 more source

Protocols for Dual Tracer PET/SPECT Preclinical Imaging

Frontiers in Physics, 2020
Background: Multi-tracer PET/SPECT imaging enables different modality tracers to be present simultaneously, allowing multiple physiological processes to be imaged in the same subject, within a short time-frame.
Julia E. Blower, Jayanta K. Bordoloi, Alex Rigby, Matthew Farleigh, Jana Kim, Hugh O'Brien, Jonathan Jackson, Constantinos Poyiatzis, James Bezer, Kavitha Sunassee, Philip J. Blower, Lefteris Livieratos   +11 more
doaj   +1 more source

Critical Appraisal of Radionuclide Calibrators and Gamma Cameras Prior to Lutetium-177 Internal Dosimetry at Two South African Hospitals

World Journal of Nuclear Medicine, 2022
Introduction The functionality of radionuclide dose calibrator and nuclear medicine imaging systems hasa direct effect on the accuracy and preciseness of internal dosimetry evaluations.
Bronwin P. Van Wyk, Francis Hasford, Nozipho E. Nyakale, M. Mboyo-Di-Tamba Vangu, Bertus Oelofse, Hector M. Leboea   +5 more
doaj   +1 more source

Preclinical efficacy of hK2 targeted [177Lu]hu11B6 for prostate cancer theranostics [PDF]

, 2019
Androgen ablating drugs increase life expectancy in men with metastatic prostate cancer, but resistance inevitably develops. In a majority of these recurrent tumors, the androgen axis is reactivated in the form of increased androgen receptor (AR ...
Beattie, Bradley J., Beattie, Kai A., Elgqvist, Jörgen, Eriksson, Sophie E., Larsson, Erik, Strand, Sven-Erik, Thorek, Daniel L. J., Timmermand, Oskar Vilhelmsson, Tran, Thuy A., Ulmert, David, Örbom, Anders   +10 more
core   +2 more sources